Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ... Science translational medicine 13 (620), eabh0272, 2021 | 147 | 2021 |
CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ... Cell reports 37 (9), 2021 | 53 | 2021 |
Proinflammatory cytokines promote TET2-mediated DNA demethylation during CD8 T cell effector differentiation CC Zebley, HA Abdelsamed, HE Ghoneim, S Alli, C Brown, D Haydar, ... Cell reports 37 (2), 2021 | 17 | 2021 |
Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration E Kouba, A Ford, CG Brown, C Yeh, GP Siegal, U Manne, IE Eltoum American Journal of Clinical Pathology 150 (2), 177-185, 2018 | 6 | 2018 |
Sample preparation of circulating cell-free DNA by direct-on-specimen and silica-based methods A Ford, C Brown, CH Yeh J Biol Sci 3 (2), 23-35, 2017 | 4 | 2017 |
Fight for children left for the crows C Brown, L Brown, A Ford, J Nisbet, M Sweet, A Donnellan, L Gruenwald Dominion Sunday Times 29, 10, 1990 | 4 | 1990 |
High concordance in advanced cancer patient paired testing by commercially available tumor tissue NGS assays and a liquid biopsy NGS assay. RC Arend, A Londono, A Martinez, A Ford, C Brown, CH Yeh, N Javadi, ... Journal of Clinical Oncology 36 (15_suppl), e24169-e24169, 2018 | 2 | 2018 |
The evolution of in situ genetic technology A Ford, C Brown, E Caver, CH Yeh Journal of Clinical Research in Oncology 1 (1), 1-5, 2018 | 2 | 2018 |
Combining circulating stromal cells with cell free DNA for increased sensitivity in profiling oncogenic mutations and indicates highly aggressive non small cell lung cancer DL Adams, SH Lin, A Raghavakaimal, G Weiss, A Ford, C Brown, CH Yeh Cancer Res 79, 437, 2019 | 1 | 2019 |
Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection A Ford, C Brown, CH Yeh | 1 | 2018 |
When liquid biopsy cell-free DNA meets with tissue biopsy RNA A Ford, C Brown, CH Yeh Biomed J Sci Tech Res 1, 256-257, 2017 | 1 | 2017 |
CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ... The Journal of Immunology 208 (1_Supplement), 122.04-122.04, 2022 | | 2022 |
CD19-CAR T Cells Develop Exhaustion Epigenetic Programs during a Clinical Response CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ... Blood 138 (Supplement 1), 2782-2782, 2021 | | 2021 |
Simultaneous cell-free RNA PD-L1 expression and MSI from the same single-tube of blood in solid tumors GJ Weiss, P Walker, D Aktas, A Ford, C Brown, CH Yeh, N Javadi Cancer Research 79 (13_Supplement), 1368-1368, 2019 | | 2019 |
Salvage genetic testing on buccal swab samples using liquid in situ amplification identifies genetic mutations from previous test failures GJ Weiss, A Ford, C Brown, E Caver, M Vallejo, C Adeyemi, F Collins, ... Cancer Research 79 (13_Supplement), 4227-4227, 2019 | | 2019 |
Real world results of liquid biopsy in stage 3/4 solid tumors and potential''clinical actionability. RC Arend, A Londono, A Martinez, A Ford, C Brown, CH Yeh, N Javadi, ... Journal of Clinical Oncology 36 (15_suppl), 2555-2555, 2018 | | 2018 |
BRAF V600E Mutations in Infarcted Thyroid Carcinoma E Kouba, A Ford, CG Brown, C Yeh, HG Kim, GP Siegal, U Manne, ... LABORATORY INVESTIGATION 97, 327A-327A, 2017 | | 2017 |
Cancer patient paired congruence between a commercially available tumor tissue and a liquid biopsy NGS assays GJ Weiss, A Ford, C Brown, CH Yeh, N Javadi Breast 9, 24.3, 0 | | |
Real world results of liquid biopsy in stage 4 solid tumors and potential “clinical actionability” GJ Weiss, A Ford, C Brown, CH Yeh, N Javadi Breast 14, 18.7, 0 | | |